Pharmaceutical Market Access and Drug Safety Act of 2009

Summary

Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 4 March 2009

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 4 March 2009

   Introduced

   Introduced in House

   Source: IntroReferral

3. 4 March 2009

   Introduced

   Introduced in House

   Source: IntroReferral

4. 5 March 2009

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 4 March 2009 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 4 March 2009

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 4 March 2009

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 4 March 2009

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Berry, Marion [D-AR-1] · D · Sponsor
• Rep. Emerson, Jo Ann [R-MO-8] · R · Sponsor
• Rep. Kildee, Dale E. [D-MI-5] · D · Cosponsor
• Rep. Carney, Christopher P. [D-PA-10] · D · Cosponsor
• Rep. Burton, Dan [R-IN-5] · R · Cosponsor
• Rep. Simpson, Michael K. [R-ID-2] · R · Cosponsor
• Rep. Taylor, Gene [D-MS-4] · D · Cosponsor
• Rep. Shea-Porter, Carol [D-NH-1] · D · Cosponsor
• Rep. Kaptur, Marcy [D-OH-9] · D · Cosponsor
• Sen. Van Hollen, Chris [D-MD] · D · Cosponsor
• Rep. Gordon, Bart [D-TN-6] · D · Cosponsor
• Rep. Wolf, Frank R. [R-VA-10] · R · Cosponsor
• Rep. Schakowsky, Janice D. [D-IL-9] · D · Cosponsor
• Rep. Hoekstra, Peter [R-MI-2] · R · Cosponsor
• Rep. Platts, Todd Russell [R-PA-19] · R · Cosponsor
• Rep. Petri, Thomas E. [R-WI-6] · R · Cosponsor
• Rep. Hastings, Doc [R-WA-4] · R · Cosponsor
• Rep. Murtha, John P. [D-PA-12] · D · Cosponsor
• Rep. McClintock, Tom [R-CA-5] · R · Cosponsor
• Rep. Arcuri, Michael A. [D-NY-24] · D · Cosponsor
• Rep. Ackerman, Gary L. [D-NY-5] · D · Cosponsor
• Rep. DeFazio, Peter A. [D-OR-4] · D · Cosponsor
• Rep. Sutton, Betty [D-OH-13] · D · Cosponsor
• Rep. Harman, Jane [D-CA-36] · D · Cosponsor
• Rep. Bishop, Timothy H. [D-NY-1] · D · Cosponsor
• Rep. Marshall, Jim [D-GA-8] · D · Cosponsor
• Rep. Bartlett, Roscoe G. [R-MD-6] · R · Cosponsor
• Rep. Costello, Jerry F. [D-IL-12] · D · Cosponsor
• Rep. Rahall, Nick J., II [D-WV-3] · D · Cosponsor
• Rep. Goodlatte, Bob [R-VA-6] · R · Cosponsor
• Rep. Tierney, John F. [D-MA-6] · D · Cosponsor
• Rep. Woolsey, Lynn C. [D-CA-6] · D · Cosponsor
• Rep. Paul, Ron [R-TX-14] · R · Cosponsor
• Rep. Duncan, John J., Jr. [R-TN-2] · R · Cosponsor
• Rep. LaTourette, Steven C. [R-OH-14] · R · Cosponsor
• Rep. Alexander, Rodney [R-LA-5] · R · Cosponsor
• Rep. Mitchell, Harry E. [D-AZ-5] · D · Cosponsor
• Rep. Kagen, Steve [D-WI-8] · D · Cosponsor
• · hsif00 · Standing

Related records

• related to ← Pharmaceutical Market Access and Drug Safety Act of 2009
• related to ← Pharmaceutical Market Access and Drug Safety Act of 2009
• related to ← Control Spending Now Act
• related to ← Fair Pricing for Prescription Drugs Act